omniture
XW LABORATORIES

Latest News

FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy

WUHAN, China, June 24, 2019 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a clinical-stage biopha...

2019-06-24 17:00 1789

XW Labs Appoints Clinical Development Veteran Dr. Daniel Canafax as Chief Medical Officer

WUHAN, China, Sept. 10, 2018 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a clinical-stage bioph...

2018-09-10 17:00 733

XW Labs Initiates First-in-Human Phase I Study for Novel Narcolepsy Treatment

WUHAN, China, March 12, 2018 /PRNewswire/ -- XW Laboratories Inc. (XW Labs) announced the initiatio...

2018-03-12 17:00 291

XW Labs Initiates First-in-Human Phase I Study for Novel Narcolepsy Treatment

WUHAN, China, March 12, 2018 /PRNewswire/ -- XW Laboratories Inc. (XW Labs) announced the initiat...

2018-03-12 17:00 726

XW Labs secures over $17M Series B financing led by Elements Capital and WI Harper

WUHAN, China, Sept. 20, 2017 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a biopharmaceutical ...

2017-09-20 17:00 1749

XW Labs Announces Exclusive Licensing Agreement with University of Pittsburgh to Develop Novel Mitochondria-Targeting Compounds

PITTSBURGH and WUHAN, China, March 6, 2017 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a biopha...

2017-03-06 18:00 2178